Holen Sie sich die Stockscreener-App
4.52
0.67%
0.03
Schlusskurs vom Vortag:
$4.49
Offen:
$4.3776
24-Stunden-Volumen:
15,545
Relative Volume:
0.21
Marktkapitalisierung:
$17.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.67M
KGV:
-1.4628
EPS:
-3.09
Netto-Cashflow:
$-101.06M
1W Leistung:
-5.04%
1M Leistung:
+11.06%
6M Leistung:
+1,538%
1J Leistung:
+629.03%
1-Tages-Spanne:
$4.3776
$4.8129
1-Wochen-Bereich:
$4.3113
$4.8618
52-Wochen-Spanne:
$0.2195
$5.00
Athira Pharma Inc Stock (ATHA) Company Profile
Firmenname
Athira Pharma Inc
Sektor
Branche
Telefon
(425) 620-8501
Adresse
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
Vergleichen Sie ATHA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATHA
Athira Pharma Inc
|
4.52 | 17.71M | 0 | -117.67M | -101.06M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-19 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-09-04 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-09-04 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-09-04 | Herabstufung | Rodman & Renshaw | Buy → Neutral |
| 2024-08-19 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-10-17 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-06-23 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-06-23 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-23 | Herabstufung | Stifel | Buy → Hold |
| 2022-05-10 | Eingeleitet | BTIG Research | Buy |
| 2022-04-21 | Eingeleitet | Berenberg | Buy |
| 2021-12-15 | Eingeleitet | Goldman | Neutral |
| 2020-10-13 | Eingeleitet | Goldman | Buy |
| 2020-10-13 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-10-13 | Eingeleitet | Jefferies | Buy |
| 2020-10-13 | Eingeleitet | Stifel | Buy |
Alle ansehen
Athira Pharma Inc Aktie (ATHA) Neueste Nachrichten
What analysts say about Athira Pharma Inc stockIndustrial Stocks Review & Start Learning With Our Courses - earlytimes.in
Why Athira Pharma Inc. stock could benefit from AI revolutionJuly 2025 Summary & High Yield Equity Trading Tips - newser.com
How Athira Pharma Inc. stock performs during Fed tightening cycles2025 Bull vs Bear & AI Powered Buy and Sell Recommendations - newser.com
Athira Pharma Inc. stock outlook for YEARGap Up & Weekly Market Pulse Updates - newser.com
Why Athira Pharma Inc. stock is popular among millennialsEarnings Trend Report & Daily Oversold Stock Bounce Ideas - newser.com
How to escape a deep drawdown in Athira Pharma Inc.Earnings Growth Summary & Consistent Return Strategy Ideas - newser.com
What makes Athira Pharma Inc. stock attractive to growth fundsJuly 2025 Breakouts & Long-Term Safe Investment Ideas - newser.com
Will Athira Pharma Inc. stock benefit from AI adoption2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
Top chart patterns to watch in Athira Pharma Inc.July 2025 EndofMonth & Real-Time Volume Triggers - newser.com
Analysts Offer Insights on Healthcare Companies: Athira Pharma (ATHA) and Cartesian Therapeutics (RNAC) - The Globe and Mail
What indicators show strength in Athira Pharma Inc.July 2025 Pullbacks & Capital Efficient Trade Techniques - newser.com
What analyst consensus says on Athira Pharma Inc. stock2025 Market Outlook & Capital Efficient Trade Techniques - newser.com
Will Athira Pharma Inc. continue its uptrendEarnings Growth Report & Real-Time Chart Breakout Alerts - newser.com
Update Recap: Is Athira Pharma Inc. stock ready for breakoutBull Run & Daily Chart Pattern Signal Reports - Fundação Cultural do Pará
ATHA | Athira Pharma Inc. SEC Filings - MarketWatch
Risk vs reward if holding onto Athira Pharma Inc.Quarterly Growth Report & Accurate Intraday Trading Signals - newser.com
Athira Pharma Inc. stock volume spike explainedWeekly Profit Report & Weekly Consistent Profit Watchlists - newser.com
Can Athira Pharma Inc. stock deliver consistent earnings growthDollar Strength & Long-Term Growth Portfolio Plans - newser.com
Real time alert setup for Athira Pharma Inc. performanceRate Cut & Consistent Return Strategy Ideas - newser.com
Is Athira Pharma Inc. stock cheap at current valuationJuly 2025 Review & Weekly Stock Performance Updates - newser.com
Athira Pharma Cuts Losses And Sets Sights On ALS Trials - Finimize
Athira Pharma, Inc. (ATHA) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Athira Pharma Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Finanzdaten der Athira Pharma Inc-Aktie (ATHA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
2.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):